贸易债权人 更改
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Agios Pharmaceuticals USD 13.75M 4.61M 2026-03
Alnylam Pharmaceuticals USD 126.63M 10.91M 2026-03
BioCryst Pharmaceuticals USD 15.83M 10.26M 2025-12
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Esperion Therapeutics USD 65.07M 12.44M 2025-12
Immunic USD 10.14M 2.22M 2025-12
Insmed USD 79.91M 316K 2025-12
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
Kyowa Hakko Kirin JPY 125.04B 1.32B 2025-12
MacroGenics USD 4.79M 1.15M 2025-12
Moderna USD 161M 156M 2026-03
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
PTC Therapeutics USD 45.49M 8.87M 2025-12
Puma Biotechnology USD 6.39M 962K 2025-09
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
Ultragenyx Pharmaceutical USD 31M 9.57M 2025-12
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03
Xoma USD 2.65M 1.52M 2025-09